Investor Presentation • May 14, 2024
Investor Presentation
Open in ViewerOpens in native device viewer


C E O F R O D E A R N T S E N





| Harvest volume (1,000 tons gw) | |||
|---|---|---|---|
| Group | Norway1 | ||
| 52.9 | 45.4 | ||
| Δ QoQ Δ YoY |
Δ QoQ Δ YoY |
||
| -30.2 +4.4 |
-28.3 +3.4 |
||
| Operational EBIT/kg (NOK) | |||
| Group | Norway1 | ||
| 28.6 | 34.1 | ||
| Δ QoQ Δ YoY |
Δ QoQ Δ YoY |
||
| +2.6 -10.2 |
+5.3 -7.0 |
||
| Operational EBIT (NOKm) | |||
| Group | Norway1 | ||
| 1,512 | 1,546 | ||
| Δ QoQ Δ YoY |
Δ QoQ Δ YoY |
||
| -646 -373 |
-575 -179 |

Q 1 2 0 2 4

Satisfactory results despite challenges
Finish harvest of autumn 2022 and continue with spring 2023 generation
| Q1 2024 | Q1 2023 | |
|---|---|---|
| Operating income (NOKm) |
2,786 | 2,326 |
| Operational EBIT (NOKm) |
1,186 | 1,109 |
| Harvest volume (tgw) |
27.8 | 22.2 |
| EBIT/kg (NOK) | 42.6 | 50.0 |


Weak results due to impact from string jellyfish
Finish harvest from spring 2022 and continue with autumn 2022
| Q1 2024 | Q1 2023 | |
|---|---|---|
| Operating income (NOKm) |
1,455 | 1,883 |
| Operational EBIT (NOKm) |
476 | 837 |
| Harvest volume (tgw) |
17.5 | 19.8 |
| EBIT/kg (NOK) | 27.1 | 42.3 |


• Contract share currently around 48% for Q2 24 and 30% for FY 24
| Q1 2024 | Q1 2023 | |
|---|---|---|
| Operating income (NOKm) |
6,449 | 6,239 |
| Operational EBIT (NOKm) |
-37 | -81 |
| Operational EBIT-margin (%) |
-0.6 % | -1.3 % |


Results affected by biological challenges
Expect continued high cost level in Q2 24
| Q1 2024 | Q1 2023 | |
|---|---|---|
| Operating income (NOKm) |
314 | 765 |
| Operational EBIT (NOKm) |
-6 | 204 |
| Harvest volume (tgw) |
2.8 | 6.6 |
| EBIT/kg (NOK) | -2.3 | 31.0 |


Good biological performance from both projects gives confidence for further potential
Guidance FY 2024 kept unchanged at 7,000 tonnes
| Key KPIs from production cycles | |||
|---|---|---|---|
| AOF | OF1 | ||
| Survival rate1 |
96% | 93% | High survival rate |
| Sea lice treatments |
0 | 1 | Low sea lice levels |
| Smolt size | ~2.0 kg | ~0.5 kg | Strong growth and |
| Production time | ~6 months | ~10 months | short production time |


45% of volume sold on contracts with negative contribution
Good biological status in all regions
| Q1 2024 | Q1 2023 | ||
|---|---|---|---|
| Operating income (NOKm) |
848 | 506 | |
| Operational EBIT (NOKm) |
138 | 9 | |
| Harvest volume (tgw) |
7.3 | 5.2 | |
| EBIT/kg (NOK) |
18.9 | 1.7 | |
| Fair value adjustments (NOKm) |
10 | -22 | |
| Profit after tax (NOKm) |
66 | -33 | |
| NIBD (NOKm) | 3,015 | 2,391 |


Q 1 2 0 2 4


*) Includes onerous contracts and fair value adjustments
**) Adjusted for fair value adjustments and implementation effect resource rent tax, see notes in financial report for details


All figures in NOK million


Q 1 2 0 2 4

Improved
Vaccines
Smolt VAP
Capacity

18
For more details please see annual report for 2023 - https://www.salmar.no/en/sustainability/policies-and-publications/
Salmon Living Lab will be an innovation center for improving the salmon farming value chain

An innovation center for research and collaboration
Strong and close collaboration with Cargill
Received very strong interest in the initiative
Process to find Salmon Living Lab leader well underway
Already operating through existing facilities
Milestones will be communicated continuously

19

~500 MNOK initial investment Design illustration of
For more information: www.salmonlivinglab.no

Q 1 2 0 2 4

| Q2 2024 | FY 2024 | ||||
|---|---|---|---|---|---|
| Δ Cost QoQ1 |
Δ Volume YoY2 |
Contract share3 |
Volume | Contract share3 |
|
| Norway | Slightly Lower |
Slightly lower |
~50% | 237,000 | ~30% |
| Central Norway |
Slightly lower |
Lower | 146,000 | ||
| Northern Norway |
Same level |
Slightly higher |
91,000 | ||
| SalMar Aker Ocean |
7,000 | ||||
| Icelandic Salmon |
Higher | 15,000 | |||
| Scottish Sea Farms4 |
37,000 |
1) Change from Q1 2024 2) Change from Q2 2023 3) Physical and financial fixed price contracts 4) Joint venture Scottish Sea Farms LTD through Norskott Havbruk, ownership 50%, figure depicts 100% share

For more information, please visit www.salmar.no
Annual General Meeting – 6 June 2024 Q2 2024 presentation – 20 August 2024 – Oslo Q3 2024 presentation – 12 November 2024 – Oslo




INVESTOR CONTACT: Håkon Husby, Head of IR Tel: +47 936 30 449 Email: [email protected]
The statements contained in this presentation may contain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect current expectations and assumptions as to future events and circumstances that may not prove accurate. Although SalMar believes that the assumptions and expectations implied in any such forward-looking statements are reasonable, no assurance can be given that such assumptions or expectations will prove to be correct. A number of material factors could cause actual results, performance or developments to differ materially from those expressed or implied by these forward-looking statements. Factors that may cause such a difference include but are not limited to: biological situation in hatcheries and sea farms; fish escapes; fluctuations in salmon prices; foreign exchange, credit and interest rate fluctuations; changes in the competitive climate; changes in laws and regulations. SalMar assumes no obligation to update any forward-looking statement.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.